Doxapram versus methylxanthine for apnea in preterm infants-Reference-Cited by-同舟云学术

Doxapram versus methylxanthine for apnea in preterm infants

Published:2000-10-23 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Henderson-Smart David J¹,Steer Peter A²

Affiliation:

1. Faculty of Medicine, University of Sydney; (Deceased) Central Clinical School; Sydney Australia

2. Children's Health Services District, Queensland Health; School of Medicine, Faculty of Health Sciences, University of Queensland; Brisbane Queensland Australia L8N 3Z5

Publisher

Wiley

Subject

Pharmacology (medical)

Reference16 articles.

1. Aminophylline vs doxapram in idiopthic apnea of prematurity; a double-blind controlled study;Eyal;Pediatrics,1985

2. A blinded, randomized, placebo-controlled trial to compare theophylline and doxapram for the treatment of apnea of prematurity;Peliowski;Journal of Pediatrics,1990

3. Comparison of the effectiveness of aminophylline and doxapram in the prevention of idiopathic apnea in preterm infants (transl.);Romeo;La Pediatria Medica e Chirurgica,1991

4. Observation of curative effects of Doxapram and Aminophylline on primary premature apnea;Wang;Hebei Medicine,2000

5. A comparative study about the therapeutic effect of theophylline and doxapram in apnoeic disorders;Moller;Klinische Pädiatrie,1999

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Doxapram for the prevention and treatment of apnea in preterm infants;Cochrane Database of Systematic Reviews;2023-10-25

2. Doxapram for the prevention and treatment of apnea in preterm infants;Cochrane Database of Systematic Reviews;2022-03-15

3. Treating Apnea of Prematurity;Cureus;2022-01-31

4. Apnoea of Prematurity and Neurodevelopmental Outcomes: Current Understanding and Future Prospects for Research;Frontiers in Pediatrics;2021-10-25

5. Caffeine for the Treatment of Apnea in the Neonatal Intensive Care Unit: A Systematic Overview of Meta-Analyses;Pediatric Drugs;2020-06-03